Immunogenic compositions

摘要

This disclosure relates to immunogenic compositions comprising an isolated immunogenic PcpA polypeptide and at least one additional antigen (such as for example, an isolated immunogenic polypeptide selected from the group consisting of the polyhistidine triad family of proteins (e g. PhtD) and methods of using these compositions for preventing and treating diseases caused by